Curaleaf Holdings, Inc. Stock price Canadian Securities Exchange
Equities
CURA
CA23126M1023
Pharmaceuticals
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- CAD | -.--% | -10.77% | -10.46% |
Mar. 15 | Cannabis Stocks Gain Following Rumors of Imminent Rescheduling | DJ |
Mar. 14 | Curaleaf Expanding into Czech Republic with Astrasana Pharma Partnershi | MT |
Sales 2024 * | 1.43B 1.94B | Sales 2025 * | 1.62B 2.2B | Capitalization | 3.8B 5.15B |
---|---|---|---|---|---|
Net income 2024 * | -81M -110M | Net income 2025 * | 17M 23.05M | EV / Sales 2024 * | 2.98 x |
Net Debt 2024 * | 474M 643M | Net Debt 2025 * | 802M 1.09B | EV / Sales 2025 * | 2.84 x |
P/E ratio 2024 * |
-39
x | P/E ratio 2025 * |
-120
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 60.08% |
Latest transcript on Curaleaf Holdings, Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 29 M€ | -1.64% | - | |
0.00% | 150 M€ | -1.80% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+136.06% | 2.22B | |
+87.30% | 63.49M |
- Stock
- Equities
- Stock Curaleaf Holdings, Inc.
- Stock Curaleaf Holdings, Inc. - Canadian Securities Exchange